Article Details
Retrieved on: 2024-06-03 20:26:27
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Longeveron Inc.'s new venture into contract manufacturing, leveraging their cleanroom facilities to support Secretome Therapeutics in developing cell-based therapies. This move highlights intersections between telecommunication and pharmaceutical manufacturing infrastructure.
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here